Daniel Torres
CAMP4 Therapeutics Corp [CAMP] Insider Activity: An Update for Investors
CAMP4 Therapeutics Corp’s recently made public that its 10% Owner 5AM Partners VI, LLC acquired Company’s shares for reported $4.5 ...
Heritage Financial Corp (HFWA) may enjoy gains as insiders got busy in the recent days
Heritage Financial Corp’s recent filing unveils that its President McDonald Bryan acquired Company’s shares for reported $0.43 million on Nov ...
Taking a Closer Look At Halozyme Therapeutics Inc (HALO) Following Its Recent Trade
In a filing, Halozyme Therapeutics Inc revealed its SVP, CHIEF OPERATING OFFICER Caudill Cortney unloaded Company’s shares for reported $0.28 ...
Investing in Amaze Holdings Inc (AMZE): What You Must Know
Amaze Holdings Inc’s filing revealed that its Chief Executive Officer Day Aaron acquired Company’s shares for reported $0.1 million on ...
PVH Corp (PVH) receives a Market perform rating from Telsey Advisory Group
PVH Corp’s recently made public that its Chief Executive Officer Larsson Stefan acquired Company’s shares for reported $1.0 million on ...
Keeping an Eye on The Baldwin Insurance Group Inc (BWIN) After Insider Trading Activity
The Baldwin Insurance Group Inc’s recent filing unveils that its insider Roche James Morgan unloaded Company’s shares for reported $2.42 ...
Examining the Potential Price Growth of CRISPR Therapeutics AG (CRSP)
In a filing, CRISPR Therapeutics AG revealed its Chief Executive Officer Kulkarni Samarth unloaded Company’s shares for reported $3.46 million ...
Norwegian Cruise Line Holdings Ltd (NCLH) may enjoy gains as insiders got busy in the recent days
Norwegian Cruise Line Holdings Ltd’s filing revealed that its SVP & Chief Accounting Officer Ashby Faye L. unloaded Company’s shares ...
Taking a Closer Look At Quanex Building Products Corp (NX) Following Its Recent Trade
Quanex Building Products Corp’s recently made public that its OBSERVER SEAT ON BOARD Teleios Capital Partners GmbH unloaded Company’s shares ...
Investing in Akari Therapeutics Plc ADR (AKTX): What You Must Know
Akari Therapeutics Plc ADR’s recent filing unveils that its CEO Gaslightwala Abizer acquired Company’s shares for reported $9400.0 on Aug ...
